文献速递前列腺癌

前列腺癌外照射放疗治疗相关毒性的长期发生率及生活质量结局

The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer.
PubMed 文献 · Urology · 2023-05-25

基于CaPSURE纵向登记数据库,评估1994至2017年间接受外照射放疗的前列腺癌患者长期治疗相关毒性发生率及生活质量变化。中位随访7.9年,任何毒性中位发生时间4.3年,最常见为出血性膀胱炎(8年时5.9%),重复测量混合模型显示出血性膀胱炎发生与总体健康随时间变化相关。

要点

  • 任何毒性中位发生时间为4.3年,可在治疗后多年出现。
  • 8年时出血性膀胱炎发生率5.9%,为最常见毒性。
  • 出血性膀胱炎发生与总体健康随时间变化相关。

核心结论

  • 前列腺癌外照射放疗与独特的治疗相关毒性相关,这些毒性可在治疗后多年发生并影响生活质量。

研究设计与样本

  • 纵向、全国性前列腺癌登记数据库CaPSURE研究,纳入1994至2017年间接受外照射放疗的男性。
  • 从15332例中识别出1744例(11.4%)接受外照射放疗者,中位随访7.9年(四分位距4.3-12.7)。

主要发现

  • 任何毒性(包括使用尿垫)的中位发生时间为4.3年(四分位距1.8-8.0),265例(8年时15.4%)使用尿垫。
  • 出血性膀胱炎104例(8年时5.9%),中位发生时间3.7年(1.3-7.8)。
  • 胃肠道毒性48例(8年时2.7%),中位发生时间4.2年(四分位距1.3-7.8)。
  • 尿道狭窄47例(8年时2.4%),中位发生时间3.7年(四分位距1.9-9.1)。
  • 重复测量混合模型发现出血性膀胱炎发生与总体健康随时间变化相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the long-term incidence of treatment-related toxicities and quality of life (QOL) outcomes associated with toxicity after external beam radiotherapy (EBRT) for prostate cancer. METHODS: We identified all men who had EBRT between 1994 and 2017 from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a longitudinal, nationwide prostate cancer registry. CaPSURE was queried for patient-reported and International Classification of Diseases-9/10 and Current Procedural Terminology codes. The Medical Outcomes Studies Short Form 36 and the University of California, Los Angeles Prostate Cancer Index were used to provide measures of general health, sexual, urinary, and bowel function. Repeated measures mixed models were used to determine QOL change after onset of toxicity. RESULTS: From a total of 15,332, 1744 (11.4%) men had EBRT. The median follow-up was 7.9years (interquartile range [IQR] 4.3-12.7). The median time to onset of any toxicity including urinary pad usage in 265 (15.4% at 8years) men was 4.3years (IQR 1.8-8.0). The most frequent toxicity was hemorrhagic cystitis (104, 5.9% at 8years) after a median of 3.7years (1.3-7.8), gastrointestinal (48, 2.7% at 8years) after a median of 4.2years (IQR 1.3-7.8), followed by urethral stricture (47, 2.4% at 8years) after a median of 3.7years (IQR 1.9-9.1). Repeated measures mixed models found that onset of hemorrhagic cystitis was associated with change in general health over time. CONCLUSION: EBRT for prostate cancer is associated with distinct treatment-related toxicities which can occur many years after treatment and can affect QOL. These results may help men understand the long-term implications of treatment decisions.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lonergan PE, Baskin A, Greenberg SA, et al. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023. PMID: 37244430. doi:10.1016/j.urology.2023.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。